E
S
D
E
European Society for
Diseases of the Esophagus
XII Congress of the
European Society for
Diseases of the Esophagus
Bologna November 20-22, 2014
Royal Hotel Carlton
Final
program
XII Congress of the European Society for Diseases of the Esophagus
Thanks to
www.gvmnet.it
2
Bologna November 20-22, 2014 | Royal Hotel Carlton
Endorsed by
European Association for Endoscopic Surgery
Italian Group for the Study of Gastroenterology and Motility
European Society of Neurogastroenterology and Motility
International Society for Diseases of the Esophagus
3
XII Congress of the European Society for Diseases of the Esophagus
CHAIR OF THE CONGRESS
Sandro Mattioli
Department of Medical and Surgical Sciences (DIMEC)
Alma Mater Studiorum - University of Bologna, Italy
Thoracic Surgery
Maria Cecilia Hospital, Cotignola
SCIENTIFIC SECRETARIAT
Leda Manara, M. Luisa Lugaresi
Department of Medical and Surgical Sciences (DIMEC)
Alma Mater Studiorum - University of Bologna, Italy
ORGANIZING SECRETARIAT
I&C srl
Via Andrea Costa, 202/6
40134 Bologna, Italy
Tel: +39 051.6144004 - Fax: +39 051.6142772
E-mail: chiara.cilione@iec-srl.it
www.iec-srl.it
4
Bologna November 20-22, 2014 | Royal Hotel Carlton
ESDE STEERING COMMITTEE
Manuel Pera, Barcelona (ES) - President
Peter D. Siersema, Utrecht (NL) - General Secretary
Christophe Mariette, Lille (FR) - Treasurer
ESDE CONGRESS SCIENTIFIC COMMITTEE
Michael S. Griffin, Newcastle upon Tyne (UK)
Christophe Mariette, Lille (FR)
Sandro Mattioli, Bologna (I)
Manuel Pera, Barcelona (ES)
Peter Siersema, Utrecht (NL)
J. Jan Van Lanschot, Rotterdam (NL)
ESDE CONGRESS LOCAL COMMITTEE
Fabio Baldi, Bologna (I)
Giovanni Barbara, Bologna (I)
Francesco Bassi, Bologna (I)
Franco Bazzoli, Bologna (I)
Stefano Brusori, Bologna (I)
Carlo Calabrese, Bologna (I)
Niccolò Daddi, Bologna (I)
Roberto De Giorgio, Bologna (I)
Massimo Di Simone, Bologna (I)
Luca Ferruzzi, Cotignola (I)
Marzio Frazzoni, Modena (I)
Nico Pagano, Bologna (I)
Vladimiro Pilotti, Cotignola (I)
Vincenzo Stanghellini, Bologna (I)
Francesco Torresan, Bologna (I)
Rocco Maurizio Zagari, Bologna (I)
5
XII Congress of the European Society for Diseases of the Esophagus
SUMMARY
Thursday, November 20
pag. 8
Friday, November 21
pag. 13
Saturday, November 22
6
General information
Exhibition area
pag. 20
pag. 24
pag. 30
Bologna November 20-22, 2014 | Royal Hotel Carlton
FACULTY
Derek Alderson, Bristol (UK)
Vito Annese, Florence (Italy)
Mario Anselmino, Pisa (Italy)
Stephen Attwood, North Tyneside (UK)
Qasim Aziz, London (UK)
Fabio Baldi, Bologna (Italy)
Giovanni Barbara, Bologna (Italy)
Franco Bazzoli, Bologna (Italy)
Rosario Bellini, Pisa (Italy)
Mario Bernardi, Bologna (Italy)
Guy Boeckxstaens, Leuven (Belgium)
Luigi Bolondi, Bologna (Italy)
Luigi Bonavina, Milan (Italy)
Albert J. Bredenoord, Amsterdam (The
Netherlands)
Carlo Castoro, Padua (Italy)
Vanna Chiarion Sileni, Padua (Italy)
Mario Costantini, Padua (Italy)
Roberto De Giorgio, Bologna (Italy)
Tom R. DeMeester, Los Angeles CA (USA)
Natale Di Martino, Caserta (Italy)
Matteo Fassan, Padua (Italy)
Karl H. Fuchs, Frankfurt (Germany)
Michael S. Griffin, Newcastle upon Tyne (UK)
Arnulf Hölscher, Cologne (Germany)
Peter J. Kahrilas, Chicago IL (USA)
Sheila K. Krishnadath, Amsterdam (The
Netherlands)
Toni Lerut, Leuven (Belgium)
Christophe Mariette, Lille (France)
Sandro Mattioli, Bologna (Italy)
Gianluigi Melotti, Modena (Italy)
Mario Morino, Turin (Italy)
Philippe Nafteux, Leuven (Belgium)
Francesca Negri, Parma (Italy)
Magnus Nilsson, Stockholm (Sweden)
Roberto Penagini, Milan (Italy)
Manuel Pera, Barcelona (Spain)
Loris Pironi, Bologna (Italy)
Bernhard Polzer, Regensburg (Germany)
Shaun Preston, Newcastle upon Tyne (UK)
John V. Reynolds, Dublin (Ireland)
Riccardo Rosati, Milan (Italy)
Massimo Rugge, Padua (Italy)
Alberto Ruol, Padua (Italy)
Jarmo Salo, Helsinki (Finland)
Stefano Santi, Pisa (Italy)
Edoardo V. Savarino, Padua (Italy)
Paul M. Schneider, Zurich (Switzerland)
Peter D. Siersema, Utrecht (The
Netherlands)
Andreas Smout, Amsterdam (The
Netherlands)
Eduardo M. Targarona, Barcelona (Spain)
Richard Van Hillegersberg, Utrecht (The
Netherlands)
Jan J. Van Lanschot, Rotterdam (The
Netherlands)
Thomas N. Walsh, Dublin (Ireland)
Kenneth Wang, Rochester MN (USA)
Giovanni Zaninotto, London (UK)
7
XII Congress of the European Society for Diseases of the Esophagus
THURSDAY, NOVEMBER 20
PRE-CONGRESS COURSES
11.30
15.30
SURGERY - SATURNO A HALL
Meet the surgeon-video session: a row of surgical procedures
Discussion on indications, surgical strategy, how I do it (comparison among different ways to do the same operation) and details of techniques among attendees and presenting surgeons.
Chairs: A. Hölscher (D), T. Lerut (BE), S. Mattioli (I)
Esophageal diverticula
•Transoral diverticulo-esophagostomy for treatment of Zenker’s diverticulum, R. Rosati (I)
•Trans axillary robotic Zenker’s diverticulectomy, G. Melotti (I)
•Treatment of large epiphrenic diverticula, S. Santi (I)
GERD and Hiatus Hernias
•Laparoscopic Nissen funduplication, P. Nafteux (BE)
•Laparoscopic Collis-Nissen in patients with short esophagus and large paraesophageal hernia, M. Pera (ES)
•Surgical therapy for short esophagus: the intra operative assessment of the length of the esophagus and
the laparoscopic-left thoracoscopic Collis-Nissen, S. Mattioli (I)
8
Achalasia
•A technical detail to improve surgery for sigmoid achalasia, S. Mattioli (I)
•Laparoscopic assisted esophagectomy for end stage achalasia, N. Di Martino (I)
Bologna November 20-22, 2014 | Royal Hotel Carlton
Esophageal cancer
•Open transhiatal esophagectomy for adenocarcinoma of the (distal) esophagus and cardia,
J.J. Van Lanschot (NL)
•Prone thoracoscopic esophagectomy, L. Bonavina (I)
•A Game-Changer In Oesophago-Gastric Surgery, T. N. Walsh (IRL)
•Hybrid esophagectomy for adenocarcinoma - Laparoscopic gastrolysis and transthoracic esophagectomy,
A. Hölscher (D)
•How to perform the lymphadenectomy at oesophagectomy, D. Alderson (UK)
•Robot-assisted thoraco-laparoscopic esophagectomy (RAMIE) in Esophageal Cancer Surgery,
R. Van Hillegersberg (NL)
13.30 GASTROENTEROLOGY - SATURNO B HALL
Advances in understanding and management of esophageal diseases with the use of modern 15.30
functional testing motility devices
Chairs: F. Baldi (I), P. J. Kahrilas (USA)
•High resolution manometry (HRM), P. J. Kahrilas (USA)
•Adding impedance to HRM: is it clinically relevant? A. Smout (NL)
•pH impedance monitoring: how useful for the management of patients? E. V. Savarino (I)
•Wireless pH monitoring (Bravo): the added value of prolonged pH monitoring, R. Penagini (I)
9
XII Congress of the European Society for Diseases of the Esophagus
16.00 OPENING CEREMONY AND WELCOME - MAIN HALL
S. Mattioli, Chair of the Congress (I)
L. Bolondi, President of the School of Medicine, Alma Mater Studiorum, University of Bologna (I)
E. Sansavini, President of Gruppo Villa Maria
16.15 OPENING LECTURE
BARRETT’S ESOPHAGUS: FROM BIOMARKERS TO ENDOSCOPIC TISSUE TRANSPLANTION
K. Wang (USA)
16.45 PLENARY SESSION 1 - MAIN HALL
ESDE PRIZE - SELECTED ORAL PRESENTATIONS
Chairs: M. Pera (ES), P. Siersema (NL)
C1
THE IMPACT OF SEVERE ANASTOMOTIC LEAK ON LONG-TERM SURVIVAL AND CANCER RECURRENCE
FOLLOWING SURGICAL RESECTION FOR ESOPHAGEAL MALIGNANCY
10
Sheraz Markar1, Caroline Gronnier2, 3, 4, Alain Duhamel5, 6, Jean-Yves Mabrut7, Jean-Pierre Bail8, Nicolas Carrere9, Jérémie H Lefevre10, Cécile
Brigand11, Jean-Christophe Vaillant12, Mustapha Adham13, Simon Msika14, Nicolas Demartines15, Issam El Nakadi16, Bernard Meunier17, Denis
Collet18, Christophe Mariette2, 3, 4, 5 ,, on behalf of the FREGAT working group – FRENCH – AFC
Department of Surgery & Cancer, Imperial College, London, UK (1), Department of digestive and oncological surgery, Claude Huriez
University Hospital, Lille, France (2), North of France University, Lille, France (3), Inserm, UMR837, Team 5 “Mucins, epithelial differentiation
and carcinogenesis”, JPARC, Lille, France (4), SIRIC OncoLille, France (5), Department of biostatistics, University Hospital, Lille, France (6),
Departments of digestive surgery of Croix-Rousse University Hospital, Lyon, France (7), Cavale Blanche University Hospital, Brest, France (8),
Purpan University Hospital, Toulouse, France (9), Saint Antoine University Hospital, Paris, France (10), Hautepierre University Hospital, Strasbourg,
France (11), Pitié-Salpétrière University Hospital, Paris, France (12), Edouard Herriot University Hospital, Lyon, France (13), Louis Mourier
University Hospital, Colombes, France (14), Vaudois University Hospital, Lausanne, Switzerland (15), ULB-Erasme-Bordet University Hospital,
Bruxelles, Belgium (16), Pontchaillou University Hospital, Rennes, France (17), Haut-Levêque University Hospital, Bordeaux, France (18).
Bologna November 20-22, 2014 | Royal Hotel Carlton
C2
DIAGNOSTIC PERFORMANCE OF 18F FDG PET/(CT) FOR THE DETECTION OF RECURRENT ESOPHAGEAL
CANCER AFTER TREATMENT WITH CURATIVE INTENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
L. Goense1, P.S.N. van Rossum1,2, M.G.E.H. Lam3, M. van Vulpen2, G. J. Meijer2 J. P. Ruurda1, R. van Hillegersberg1
1
Department of Surgery, University Medical Center Utrecht, The Netherlands
2
Department of Radiotherapy, University Medical Center Utrecht, The Netherlands
3
Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, The Netherlands
C3
NEOADJUVANT CHEMORADIOTHERAPY FOR CANCER OF THE ESOPHAGUS OR GE JUNCTION INHIBITS
HEART FUNCTION
Jon A. Tsai, Mikael Lund, Reidar Winter, Magnus Nilsson, Mats Lindblad, Ioannis Rouvelas, Lars Lundell, Sigridur Kalman
Karolinska University Hospital, Centre for Digestive Diseases, Stockholm, Sweden
C4
THE NATIONAL PROFICIENCY GAIN CURVE IN ENGLAND FOR MINIMALLY INVASIVE ESOPHAGECTOMY
Sheraz R. Markar1, Hugh Mackenzie1, Alan Alkasari2, Omar Faiz2, George B Hanna1
1 – Department of Surgery & Cancer, Imperial College, St Mary’s Hospital, London, UK
2 – St Mark’s Hospital and Academic Institute, London, UK
C5
SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH ESOPHAGEAL ADENOCARCINOMA
Anna M.J. van Nistelrooij1,2, Linda Broer3, Katharina Biermann1, Carel J.M. van Noesel4, J. Jan B. van Lanschot2, André G. Uitterlinden3,4,
Bas P.L. Wijnhoven2, Winand N.M. Dinjens1
Departments of Pathology1, Surgery2, Internal Medicine3, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Department of Patholgy4, Academic Medical Center, Amsterdam, The Netherlands.
11
XII Congress of the European Society for Diseases of the Esophagus
C6
CLINICAL AND HIGH RESOLUTION MANOMETRY DATA SUPPORT THE HYPOTHESIS THAT PROTON PUMP
INHIBITOR-RESPONSIVE ESOPHAGEAL EOSINOPHILIA REPRESENT A GERD-RELATED PHENOMENON
Ottavia Bartolo1, Mario Costantini2, Chiara de Cassan1, Roberta Caccaro1, Francesca Galeazzi1, Loredana Nicoletti2, Tiziana Morbin2, Lisa
Zanatta2, Salvatore Tolone1, Renato Salvador 3, Giacomo Carlo Sturniolo1, Stefano Merigliano2, Edoardo V. Savarino1
1
Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
2
U.O. Clinica Chirurgica 3, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
3
Chirurgia Generale, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
18.45 HONORARY MEMBERSHIP LECTURE
THE CHALLENGE OF PROGRESSIVE DISEASE IN GERD
T.R. DeMeester (USA)
19.15 SOCIETAL AFFAIRS
M. Pera (ES)
19.30 Welcome Reception
12
Bologna November 20-22, 2014 | Royal Hotel Carlton
FRIDAY, NOVEMBER 21
8.00
ORAL PRESENTATIONS - Session 1 - MAIN HALL
Chairs: P. Nafteux (BE), E. V. Savarino (I)
C7
THE PROGNOSTIC IMPACT OF ISOLATED TUMOR CELLS (ITCS) IN LYMPH NODES OF PN0 ESOPHAGEAL
CANCER
Laura Albertoni, Lavinia Stefanizzi, Alberto Ruol, Carlo Castoro, Luciano Giacomelli, Claudia Mescoli, Giovanni Zaninotto, Massimo Rugge
Department of Diagnostic Sciences & Special Therapies (Pathology & Cytopathology Section); University of Padua, Padua, Italy.
C8
HYBRID MINIMALLY INVASIVE VERSUS OPEN OESOPHAGECTOMY FOR PATIENTS WITH OESOPHAGEAL
CANCER: A MULTICENTRE, OPEN-LABEL, RANDOMISED PHASE III CONTROLLED TRIAL, THE MIRO TRIAL
Christophe Mariette (1), Bernard Meunier (2), Denis Pezet (3), Cécile Dalban (4), Denis Collet (5), Pascal-Alexandre Thomas (6), Cécile Brigand
(7), Thierry Perniceni (8), Nicolas Carrere (9), Franck Bonnetain (4), Guillaume Piessen (1)
Department of Surgery at the Lille (1), Rennes (2), Clermont Ferrand (3), Bordeaux (5), Marseille (6), Strasbourg (7), Institut Mutualiste
Montsouris (8), Toulouse (9) University Hospitals and Department of Biostatistics, Dijon (4), France
C9
MUCOSAL PERFORATION DURING LAPAROSCOPIC HELLER MYOTOMY DOESN’T INFLUENCE THE FINAL
OUTCOME OF THE TREATMENT
Renato Salvador MD FACS, Mario Costantini MD, Cristina Longo MD, Lisa Zanatta MD, Loredana Nicoletti, Giovanni Capovilla MD, Francesca
Galeazzi MD, Edoardo Savarino MD, PhD, Giovanni Zaninotto MD FACS
Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, School of Medicine, Padua, Italy
13
XII Congress of the European Society for Diseases of the Esophagus
C10
MICROSATELLITE INSTABILITY IN BARRETT ESOPHAGUS; FROM INTESTINAL METAPLASIA TO
ESOPHAGEAL ADENOCARCINOMA
Markos Pave1, Brcic Iva2, Brcic Luka2, Jakic-Razumović Jasminka2, Pulanic Roland1
Division of Gastroenterology and Hepatology, Univesity Hospital Centre Zagreb
2
Clinical Department for Pathology and Cytology, University Hospital Center Zagreb, Zagreb School of Medicine
1
C11
MULTIPLE RAPID SWALLOWING IS A USEFUL COMPLEMENTARY TEST TO CORRELATE SYMPTOMS TO
ESOPHAGEAL MOTILITY ABNORMALITIES
Edoardo V. Savarino1, Chiara de Cassan1, Francesca Galeazzi1, Renato Salvador2, Moira Rigato1, Elisa Marabotto3, Manuele Furnari3,
Giorgia Bodini3, Patrizia Zentilin3, Nicola de Bortoli4, Santino Marchi4, Romeo Bardini2, Giacomo Carlo Struniolo1, Vincenzo Savarino3
1
Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
2
General Surgery, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
3
Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy
4
Division of Gastroenterology, Department of Internal Medicine, University of Pisa, Pisa, Italy
C12
LIVER CIRRHOSIS IS NOT AN ABSOLUTE CONTRAINDICATION TO RADICAL SURGERY FOR ESOPHAGEAL
CANCER. RESULTS OF A CASE CONTROL STUDY.
C. De Pasqual, M. Valmasoni, G. Zanchettin, S. E. Pierobon, A. Caudo, M. Costantini, S. Merigliano, A. Ruol
Clinica Chirurgica 3, University of Padua, Padua, Italy.
14
Bologna November 20-22, 2014 | Royal Hotel Carlton
9.00
PLENARY SESSION 2 - MAIN HALL
Chairs: M. Nilsson (SE), A. Smout (NL)
HOT TOPICS IN GERD
•The acid pocket in health and GERD, G. Boeckxstaens (BE)
•Hiatus hernia and cardial incontinence, P. Kahrilas (USA)
•Surgery for refractory GERD, M. Nilsson (SE)
•Obesity and GERD; pathophysiology and surgical therapy, M. Anselmino (I)
10.30 Coffee break & Posters Visit
P1- P15 Chairs: G. Boeckxstaens (BE), M. Nilsson (SE)
11.00 PARALLEL SESSIONS 1
SURGERY 1 (JOINT SESSION ESDE/EAES): SURGERY FOR TYPE II-IV HIATUS HERNIA - MAIN HALL
Chairs: D. Alderson (UK), M. Morino (I)
•Natural history of type II-IV HH and the indications for surgical therapy, J. Salo (FI)
•Surgical therapy: open vs minimally invasive techniques, K. H. Fuchs (D)
•Causes and timing of hernia relapse, L. Bonavina (I)
•Cruroplasty: pros and cons of bio-prosthetic materials, E. M. Targarona (ES)
15
XII Congress of the European Society for Diseases of the Esophagus
GASTROENTEROLOGY 1 (Joint session ESDE/ ESNM) - GIOVE HALL
COMMON PATHOGENETIC MECHANISMS IN FUNCTIONAL GASTRO-INTESTINAL DISORDERS
Chairs: G. Boeckxstaens (BE), R. De Giorgio (I)
•Sensory-motor dysfunction, Q. Aziz (UK)
•Luminal factors, microbiota and mucosal barrier, G. Barbara (I)
•Neuro-immune interactions - New targets for treatment, G. Boeckxstaens (BE)
12.30 Lunch & Posters Visit
P16 - P30 Chairs: F. Baldi (I), J. Salo (FI)
13.30 GENERAL ASSEMBLY - MAIN HALL
14.15 ORAL PRESENTATIONS - Session 2 - MAIN HALL
Chairs: N. Di Martino (I), P. Siersema (NL)
C13
INSIGHTS IN WORK REHABILITATION AFTER MINIMALLY INVASIVE ESOPHAGECTOMY: A TWO-CENTRE STUDY
Luis Carlos Silva Corten1, Misha D.P. Luyer2, Srdjan Rakic1, Grard A.P. Nieuwenhuijzen2, Marc J. van Det1, Ewout A. Kouwenhoven1
1. Department of Surgery, ZGT-Hospital Group Twente, Almelo, The Netherlands
2. Department of Surgery, Catherina Hospital, Eindhoven, The Netherlands
C14
ESTROGEN RECEPTORS AND ESOPHAGEAL CANCER: A POTENTIAL THERAPEUTIC PATHWAY
16
Waleed Al-Khyatt, Cristina Tufarelli, Raheela Khan, Syed Y Iftikhar
School of Graduate Entry Medicine and Health, University of Nottingham, Royal Derby Hospital, Uttoxeter Road, Derby, United Kingdom.
Bologna November 20-22, 2014 | Royal Hotel Carlton
C15
WHOLE-GENOME TRANSCRIPTOME ANALYSIS REVEALS NOVEL GENE EXPRESSION ALTERATIONS IN
ACHALASIA
Elena Bonora1, Francesca Bianco1, Marialuisa Lugaresi1, Ottorino Perrone1,Vincenzo Stanghellini1, Annalisa Astolfi2, Valentina Indio2, Francesco
Torresan1, Alexandros Ioannou1, Fabio Baldi1, Giovanni Barbara1, Alessandra Gori1 and Roberto De Giorgio1
1
Department of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum University of Bologna, Bologna, Italy
2
Interdipartimental Centre for Cancer Research “Giorgio Prodi”, Alma Mater Studiorum University of Bologna, Bologna, Italy
C16
SIGNIFICANCE OF NISSEN FUNDOPLICATION AFTER ENDOSCOPIC RADIOFREQUENCY ABLATION OF
BARRETT ESOPHAGUS
Skrobić O, Simić A, Veličković D, Djurić-Stojanović A, Šljukić V, Ivanović N, Peško P.
Department of Esophagogastric Surgery, First Surgical University Hospital, Belgrade, Serbia
C17
COMPUTED TOMOGRAPHY FOR STAGING OF OESOPHAGEAL AND JUNCTIONAL CANCER: DO WE NEED
A DEDICATED REPORTING TEMPLATE?
Mathieu Messager1,3, Gina Brown2, William H Allum1
1. Department of Surgery, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
2. Radiology Department, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
3. Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Lille, France
17
XII Congress of the European Society for Diseases of the Esophagus
C18
AN ENHANCED RECOVERY PROGRAM WITH THE EARLY INTRODUCTION OF ORAL FEEDING FOLLOWING
MINIMALLY INVASIVE OESOPHAGECTOMY IS WELL TOLERATED AND IS ASSOCIATED WITH LOW
MORBIDITY AND EXCELLENT NUTRITIONAL AND PATIENT-REPORTED OUTCOMES
T. Murphy#, S. Cushen*, A. Griffiths^, A. Ryan*
*Department of Nutrition, University College Cork
^Department of Anaesthetics, Mercy University Hospital, Cork
#
Department of Surgery, Mercy University Hospital, Cork
15.15 PLENARY SESSION 3 - MAIN HALL
MANAGEMENT OF NON ACHALASIA ESOPHAGEAL MOTOR DISORDERS
(Joint Session ESDE/GISMAD)
Chairs: R. Penagini (I), R. Van Hillegersberg (NL)
•Clinical and patho-physiologic patterns, A. Smout (NL)
•Pharmacological and dilation treatment, V. Annese (I)
•Surgical options, G. Zaninotto (UK)
16:30 LECTURE
SURGICAL AND NON SURGICAL THERAPY FOR ESOPHAGEAL ACHALASIA. MAY THE OLD HELP THE NEW?
S. Mattioli (I)
17.00 Coffee break & Posters Visit
P31 - P50 Chairs: C. Mariette (FR), P.D. Siersema (NL)
18
Bologna November 20-22, 2014 | Royal Hotel Carlton
17.30 LECTURES
CANCER OF THE ESOPHAGUS
Chairs: J.J. Van Lanschot (NL), T. N. Walsh (IRL)
•A prediction model for risk stratification of Barrett’s esophagus, S. K. Krishnadath (NL)
•Molecular characterization of disseminated and circulating tumor cells:
insights into metastasis and diagnostic consequences, B. Polzer (D)
•Target therapy: how and when, F. Negri (I)
18.15 PLENARY SESSION 4 - MAIN HALL
THE SEQUENCE METAPLASIA/DYSPLASIA/ADENOCARCINOMA OF THE ESOPHAGUS AND CARDIA
Chairs: C. Mariette (FR), P. M. Schneider (CH)
•The pathogenesis of conversion from squamous to columnar epithelium in the esophagus, M. Pera (ES)
•The presence/absence of goblet cells in the sequence metaplasia/dysplasia/cancer, M. Fassan (I), M. Rugge (I)
•The relationship between tumor’s biology and lymphatic metastases, A. Ruol (I)
•A standard or a tailored surgery for adenocarcinoma of the esophagus and cardia? A. Hölscher (D)
19.15Conclusion
20.30 Faculty dinner
19
XII Congress of the European Society for Diseases of the Esophagus
SATURDAY, NOVEMBER 22
8.30
ORAL PRESENTATIONS - Session 3 - MAIN HALL
Chairs: A. J. Bredenoord (NL), M. Costantini (I)
C19
PROTON PUMP INHIBITOR RESPONSIVE VS. NON-RESPONSIVE FUNCTIONAL HEARTBURN: THE
DIFFERENCE LIES IN THE IMPEDANCE BASELINE
de Bortoli N1, Martinucci I1, Savarino E2, Tutuian R3, Frazzoni M4, Bertani L1, Laino G1, Russo S1, Furnari M5, Bellini M1, Savarino V5, Marchi S1.
1
Division of Gastroenterology, Department of Traslational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
2
Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
3
Gastroenterology Unit, Hospital of Bern, Switzerland
4
Gastroenterology Unit, Hospital of Modena, Italy
5
Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy
C20
ESOPHAGEAL PERFORATION FOLLOWING ANTERIOR CERVICAL SPINE FIXATION (ACDF). MANAGEMENT
AND RESULTS
Perrone O., Lugaresi M., Borghesi I., Belloni GP., Uneddu M
Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy
C21
IN-FIELD CONTROL OF MULTIMODAL THERAPY IN LOCALLY ADVANCED ESOPHAGEAL CANCER
20
H. Thoen1, W. Ceelen1, T. Boterberg2, E. Van Daele1, P. Pattyn1
1
Ghent University – Department of Surgery, Belgium
2
Ghent University – Department of Radiation Oncology, Belgium
Bologna November 20-22, 2014 | Royal Hotel Carlton
C22
IMPACT OF NEO-ADJUVANT CHEMOTHERAPY ON CARDIORESPIRATORY RESERVE IN
OESOPHAGOGASTRIC ADENOCARCINOMA
M. Navidi, K. Sumpter, S.M. Griffin, R.C.F. Sinclair
Northern Oesophagogastric Cancer Unit, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
C23
GASTRO-ESOPHAGEAL REFLUX AND ANTISECRETORY DRUGS USE AMONG PATIENTS WITH CHRONIC
AUTOIMMUNE ATROPHIC GASTRITIS: A STUDY WITH PH-IMPEDANCE MONITORING
Tenca A1, Pugliese D1, Massironi S1, Consonni D2, Franchina M1, Spampatti M1, Conte D1, Penagini R1
1. Gastroenterology and Endoscopy Unit - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Department of Pathophysiology
and Transplantation University of Milan, Milan, Italy.
2. Epidemiology Unit - Department of Preventive Medicine - Fondazione IRCCS
Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy.
C24
DOES OMENTOPLASTY REDUCE ANASTOMOTIC LEAK FOLLOWING ESOPHAGECTOMY? – META-ANALYSIS
Wiggins T., Markar S.R., Arya S., Hanna G.B.
Division of Surgery, Imperial College, London UK
21
XII Congress of the European Society for Diseases of the Esophagus
PARALLEL SESSIONS 2
9.30
SURGERY 2 - MAIN HALL
SAFE AND FAST TRACK ESOPHAGECTOMY
Chairs: J. V. Reynolds (IRL), R. Rosati (I)
•The ERAS protocol in esophageal surgery, S. Preston (UK)
•Evidence-based use of albumin: is there a role in patients with post-operative hypoalbuminemia?
M. Bernardi (I)
•Peri operative nutrition, L. Pironi (I)
•The management of anastomotic leaks, C. Mariette (FR)
GASTROENTEROLOGY 2 - GIOVE HALL
EOSINOPHILIC ESOPHAGITIS
Chairs: S. Attwood (UK), F. Bazzoli (I)
•Epidemiology in adults, S. Attwood (UK)
•Advances in pathogenesis, S. Attwood (UK)
•Relationship with GERD and indications of PPIs, R. Penagini (I)
•Current management and guidelines, A. J. Bredenoord (NL)
11.00 Coffee break
22
Bologna November 20-22, 2014 | Royal Hotel Carlton
11.30 PLENARY SESSION 5 - MAIN HALL
PALLIATION OF DYSPHAGIA IN ADVANCED ESOPHAGEAL CANCER
Chairs: S.M. Griffin (UK), P. D. Siersema (NL)
•Techniques, results and complications of chemo-radiotherapy, V. Chiarion Sileni (I)
•Esophageal stenting: when, how and new developments, P. D. Siersema (NL)
•Indications and techniques of salvage esophagectomy, C. Castoro (I)
12.45 Prizes and closing remarks
13.00 CME-EACCME Questionnarie
23
XII Congress of the European Society for Diseases of the Esophagus
GENERAL INFORMATION
CONGRESS VENUE
Royal Hotel Carlton
Via Montebello, 8
Bologna, Italy
Tel: +39 051 249361
Fax: +39 051 249724
www.monrifhotels.it/RoyalCarltonHotel
24
EACCME ACCREDITATION
European cme credits
The “XII CONGRESS OF THE EUROPEAN
SOCIETY FOR DISEASES OF THE
ESOPHAGUS-ESDE” is accredited by
the European Accreditation Council for
Continuing Medical Education (EACCME) to provide
the following CME activity for medical specialists.
How to reach the venue
The EACCME is an institution of the European Union
The Royal Hotel Carlton is located in the centre of
of Medical Specialists (UEMS), www.uems.net.
Bologna, walking distance from the Railway Station and The “XII CONGRESS OF THE EUROPEAN SOCIETY FOR
Piazza Maggiore.
DISEASES OF THE ESOPHAGUS-ESDE” is designated for a
maximum of 12 hours of European external CME credits.
By car: From the highway, exit n. 7/City Centre - Fair, Each medical specialist should claim only those hours of
following the indications for the Railway Station - Set the
credit that he/she actually spent in the educational activity.
navigation system for Via Milazzo 6 to avoid the restricted
Through an agreement between the European Union
traffic zone.
of Medical Specialists and the American Medical
Association, physicians may convert EACCME credits to
By plane: Guglielmo Marconi International Airport is 15 an equivalent number of AMA PRA Category 1 Credits™.
minutes from the Hotel. Airbus shuttle services depart
Information on the process to convert EACCME credit
every 20 minutes from the Airport to the Station.
Bologna November 20-22, 2014 | Royal Hotel Carlton
to AMA credit can be found at www.ama-assn.org/go/internationalcme. Live educational activities, occurring
outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning
Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and
Surgeons of Canada.
Event code: 11336
N. 12 European CME credits (ECMEC) granted by the European Accreditation Council for Continuing Medical
Education (EACCME). Each medical specialist should claim only those hours of credit that he/she actually spent in the
educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half
a day and 6 ECMECs for a full-day event.
Italian cme credits
ESDE 2014 is accredited for Physicians (Specialties: Gastroenterology, General Surgery, Internal Medicine, Oncology,
Thoracic Surgery, Radiation Oncology, Radiology, Vascular Surgery, Pathological Anatomy).
The Physicians belonging to other disciplines will not get the credits.
Provider: I&C srl n. 1740-108049
CME credits: 7,5
Pre Congress Courses are not accredited.
Checking Method
An effective presence to all meeting sessions as well as a correct answer to the at least 75% of the CME
questionnaire are needed to get the CME credits. No exception will be considered.
25
XII Congress of the European Society for Diseases of the Esophagus
ESDE PRIZE AND SELECTED ORAL PRESENTATIONS
This prize has been created in the attempt to promote research and interest of young surgeons and gastroenterologists
in the area of esophageal diseases. Abstracts submitted to the congress will be evaluated blindly by a panel composed of
surgeons and gastroenterologists. The six abstracts scored with the highest marks will participate in the ESDE competition.
The Scientific Committee will elect the ESDE prize winner on the base of the scientific content of the presentation, the
quality of exposition and discussion. The best presentation shall be rewarded with a prize of € 1000,00; presenters in
the ESDE prize shall be recognized with a parchment.
Abstracts selected for oral presentation will be considered for pubblication in Diseases of the Esophagus,
“after peers review”.
POSTERS
Poster exposure is scheduled on November 21 in SATURNO HALL A and B at the following time:
•10.30-11.00 Coffee Break and Poster Visit - P1- P15
•12.30-13.30 Lunch and Poster Visit - P16 - P30
•17.00-17.30 Coffee Break and Poster Visit - P31 - P50
In a panel located nearby the Poster Area, the number of posters sequence will be diplayed.
Mounting Time: you must fix your poster compulsorily from 08.00 to 19.00 of November 21 2014.
Dismounting Time: you are requested to dismount your poster on November 21 from 19.00 to 19.30.
26
At 19.30 of November 21 our Organization will remove and eliminate all posters not dismounted by presenters.
The exposed posters will compete in the “posters prize”. The first one cassified will be rewarded with a prize of € 500,00.
A parchment will be given to the first, the second and the third one classified.
Oral Presentations and Posters are collected in a USB memory.
Bologna November 20-22, 2014 | Royal Hotel Carlton
REGISTRATION FEE
Costs including VAT 22%
□ MEMBER ESDE
□ NON MEMBER ESDE
□ RESIDENT/TRAINEE
□ PRE-CONGRESS COURSE
On site registrations
€ 300,00
€ 400,00
€ 150,00
€ 120,00
The registration fee covers:
•Admission to scientific sessions
•Congress kit
•Coffee breaks and lunch
•Welcome cocktail
•Abstracts of the Congress on USB memory
CANCELLATION POLICY
•100% refund for request sent to the Organizing Secretariat before September 30 2014
•After September 30 no refund for the registration fee will be possible
OFFICIAL LANGUAGE
English is the official language of the Meeting.
Simultaneous translation is not provided.
27
XII Congress of the European Society for Diseases of the Esophagus
TECHNICAL FACILITIES
Facilities will be available for computer presentations.
The Slide Center with PC will be available in the main hall for check and preview the presentations.
It is essential that speakers deliver their presentation to the slide center at least one hour before the session starts.
CERTIFICATE OF ATTENDANCE
The certificate of attendance will be available, on request, at the end of the Congress at the Secretariat.
ORGANIZING SECRETARIAT
I&C srl
Via Andrea Costa, 202/6
40134 Bologna, Italy
Tel: +39 051.6144004 - Fax: +39 051.6142772
E-mail: chiara.cilione@iec-srl.it
www.iec-srl.it
The Organizing Secretariat will be open during conference time.
28
Bologna November 20-22, 2014 | Royal Hotel Carlton
The Scientific Committee wish to thank the following companies for the unrestricted
contribution to the ESDE Congress:
29
XII Congress of the European Society for Diseases of the Esophagus
EXHIBITION AREA - MAIN HALL first floor
30
Bologna November 20-22, 2014 | Royal Hotel Carlton
NOTES
31